Prosecution Insights
Last updated: October 02, 2026

Examiner: BAUER, NICOLA MARIA

Tech Center 1600 • Art Units: 1621 1629 1684

This examiner grants 58% of resolved cases

Analysis

Nicola Maria Bauer examines applications in Art Unit 1621 within Tech Center 1600. She has reached a final resolution in 60 cases, providing a focused data set for evaluating her prosecution style. The allowance rate pct of 58.3 indicates a moderate success rate, where more than half of the applications result in a patent grant. This 58.3 percent rate suggests that while success is achievable, applicants must be diligent in addressing examiner concerns. The median days to allowance is 1378, reflecting an exceptionally long prosecution timeline for successful cases. This 1378-day median indicates that practitioners should prepare for an extended period of examination in Tech Center 1600.

A critical insight from the data is the interview lift pct of 50.0. This high lift suggests that conducting an interview significantly improves the probability of allowance compared to cases without such interaction. By engaging in verbal negotiation, applicants can potentially overcome the hurdles that lead to the 58.3 percent baseline rate. Given the 1378-day median wait, an early interview may be a vital tactic for clarifying issues and moving the application toward a grant. The 60 resolved cases show that direct communication is a highly effective tool in Art Unit 1621. Practitioners should prioritize interviews as a primary method for navigating the lengthy and challenging prosecution environment associated with this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

58.3%
Allow Rate
-1.7% vs TC avg
93
Total Applications
+50.0%
Interview Lift
1378
Avg Prosecution Days
Based on 60 resolved cases, 2023–2026

Rejection Statute Breakdown

0.9%
§101 Eligibility
19.2%
§102 Novelty
51.6%
§103 Obviousness
12.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18257167 CB2 RECEPTOR AGONISTS Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18557899 STABLE ISOQUINOLINE-CORTICOSTEROID CONJUGATES AND USES THEREOF Non-Final OA ALCON INC.
18524612 PREPARATION OF FUSED AZOLE DERIVATIVES AS NOVEL DIACYLGLYCERIDE 0-ACYLTRANSFERASE 2 INHIBITORS Non-Final OA Merck Sharp & Dohme LLC
18041475 METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18063048 BINDING SITE IN TYPE 2 RYANODINE RECEPTOR Non-Final OA The Trustees of Columbia University in the City of New York

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month